• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAR
Click for more information
0.00% 29.5¢

PARADIGM BIOPHARMACEUTICALS LIMITED..

Market Cap $103.1M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company... Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company is engaged in discovering, developing, and delivering pharmaceutical therapies. It is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA) and mucopolysaccharidosis (MPS). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). It develops PPS under the brand name Zilosul. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with MPS; treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAR
research reports and media
70 71 72
10:05 4.2K 1.9M
10:05 Last post  Torpy Comments Created with Sketch.  4.2K  Views Created with Sketch.  1.9M 
PAR
The Flex? 		21/07/24 3 1.1K
21/07/24 Last post  boslo Comments Created with Sketch.  3  Views Created with Sketch.  1.1K 
PAR
LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review 		20/07/24 16 6.5K
20/07/24 Last post  Violin1 Comments Created with Sketch.  16  Views Created with Sketch.  6.5K 
PAR
PARate Day 2024 - scurvy dogs o' the ASX
2
20/07/24 105 26K
20/07/24 Last post  Babbanap Comments Created with Sketch.  105  Views Created with Sketch.  26K 
PAR
fda fast track designation 		16/07/24 1 618
16/07/24 Last post  Mozzarc Comments Created with Sketch.  1  Views Created with Sketch.  618 
PAR
The (Painful) Competition 		15/07/24 13 4.3K
15/07/24 Last post  Mozzarc Comments Created with Sketch.  13  Views Created with Sketch.  4.3K 
PAR
New Player
2
12/07/24 81 20K
12/07/24 Last post  the buck Comments Created with Sketch.  81  Views Created with Sketch.  20K 
PAR
Where we at?
10 11 12
12/07/24 706 249K
12/07/24 Last post  JamesTas Comments Created with Sketch.  706  Views Created with Sketch.  249K 

See All Discussions arrow Created with Sketch.

Timeline

Change in substantial holding
22 May 08:24
 
Application for quotation of securities - PAR
20 May 16:03
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 09:54
 
Notification of cessation of securities - PAR
26 Apr 16:46
 
Type D Response Submitted and Received by the US FDA
19 Apr 08:36
 
Notification of cessation of securities - PAR
05 Apr 19:49
 
View More arrow Created with Sketch.

Featured News

EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
(20min delay)
Last
29.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $103.1M
Open High Low Value Volume
30.0¢ 30.0¢ 29.5¢ $9.796K 32.69K

Buyers (Bids)

No. Vol. Price($)
5 57805 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 8859 4
View Market Depth
Last trade - 10.41am 22/07/2024 (20 minute delay) ?
Last
30.0¢ 		  Change
0.000 ( 1.69 %)
Open High Low Volume
30.0¢ 30.0¢ 30.0¢ 3200
Last updated 10.39am 22/07/2024 ?
PAR (ASX) Chart

Top Stories

Althea Group inks 'JV agreements' to boost marketing of cannabis-based beverage product in US market

Althea Group (ASX:AGH) has inked agreements "to establish [a] joint venture" with Flora Growth Corporation to make cannabis-based beverages.
HBF to throw 10% vote behind NDC BidCo's buyout of Pacific Smiles Group Pacific Smiles Group has confirmed 10% shareholder HBF – the private health insurer – will vote in favour of PSQ's buyout by NDC BidCo.
Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery The week that was: Donald Trump accidentally dodges bullet, China's Third Plenum a non-event & pervasive RBA August move mystery.
Woodside takes on advanced LNG project on US Gulf Coast Woodside Energy Group Ltd is set to acquire an advanced LNG project in the US Gulf Coast - Driftwood - located near Lake Charles, Louisiana.
Large fault structure and uranium anomalies picked up by Infini at Newfoundland play Infini Resources Ltd has revealed the presence of a large fault structure connected to anomalies at its Portland Creek uranium project.

Featured News

AUN Aurumin reports high-grade iron ore rock chips at Central Sandstone, WA
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
NEWS Talking Australia's very competitive property landscape: Realty Talks
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.